LENTI, MARCO VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 2.521
EU - Europa 1.982
AS - Asia 817
AF - Africa 5
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.332
Nazione #
US - Stati Uniti d'America 2.498
IE - Irlanda 1.152
CN - Cina 732
IT - Italia 304
FI - Finlandia 160
DE - Germania 128
IN - India 62
BE - Belgio 61
SE - Svezia 38
UA - Ucraina 33
CA - Canada 19
FR - Francia 18
RO - Romania 18
RU - Federazione Russa 15
GB - Regno Unito 14
CH - Svizzera 9
NL - Olanda 8
AT - Austria 7
MD - Moldavia 6
AU - Australia 5
IL - Israele 4
IR - Iran 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 3
ID - Indonesia 3
PT - Portogallo 3
SV - El Salvador 3
ES - Italia 2
ET - Etiopia 2
EU - Europa 2
MU - Mauritius 2
PL - Polonia 2
TR - Turchia 2
EG - Egitto 1
HK - Hong Kong 1
IM - Isola di Man 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
TW - Taiwan 1
VN - Vietnam 1
Totale 5.332
Città #
Dublin 1.148
Chandler 685
Ashburn 238
Nanjing 161
Helsinki 136
Princeton 134
Lawrence 132
Medford 130
Beijing 116
Shanghai 113
New York 96
Wilmington 86
Jacksonville 74
Milan 70
Brussels 61
Nanchang 61
Hebei 58
Pune 58
Shenyang 56
Ann Arbor 49
Pavia 42
Changsha 37
Jiaxing 37
Dearborn 36
Tianjin 25
Hangzhou 22
Fairfield 21
Norwalk 19
Rome 19
Woodbridge 19
Seattle 18
Falls Church 17
Timisoara 16
Houston 15
Toronto 15
Guangzhou 14
Redwood City 14
Washington 13
Chicago 11
Turin 8
Amsterdam 7
Orange 7
Vienna 7
Busto Arsizio 6
Des Moines 6
Falkenstein 6
San Francisco 6
Zurich 6
Andover 5
Brescia 5
Moscow 5
Rozzano 5
Zhengzhou 5
Boardman 4
Borås 4
Genova 4
Jinan 4
Menlo Park 4
Munich 4
Torino 4
Verona 4
Brno 3
Böblingen 3
Chisinau 3
Laives 3
Leawood 3
Melbourne 3
Ningbo 3
Paceco 3
Ramat Gan 3
San Salvador 3
Seelze 3
Addis Ababa 2
Ankara 2
Bangalore 2
Bientina 2
Bologna 2
Borgomanero 2
Buffalo 2
Cambridge 2
Camponogara 2
Cerignola 2
Como 2
Esslingen am Neckar 2
Fuzhou 2
Geneva 2
Inverigo 2
Jakarta 2
Jeddah 2
Lecco 2
Liscate 2
Makkah 2
Marcignago 2
Margherita Di Savoia 2
Milazzo 2
Naples 2
Pamplona 2
Paris 2
Pieve Emanuele 2
Revere 2
Totale 4.277
Nome #
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 80
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 79
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 74
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 74
A consensus for the development of a vector model to assess clinical complexity 66
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 63
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 61
A laboratory score in the diagnosis of autoimmune atrophic gastritis: A prospective study 59
Association between defective spleen function and primary eosinophilic gastrointestinal disorders 59
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 58
Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study 57
Increase in chromogranin A- and serotonin-positive cells in pouch mucosa of patients with ulcerative colitis undergoing proctocolectomy 56
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 56
Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis 55
Common features of patients with autoimmune atrophic gastritis. 55
Defective spleen function in autoimmune gastrointestinal disorders 55
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 55
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 54
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 54
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 53
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 53
Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases 52
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 52
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 51
Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients 51
Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab 50
Small bowel adenocarcinomas featuring special at-rich sequence-binding protein 2 (Satb2) expression and a colorectal cancer-like immunophenotype: A potential diagnostic pitfall 50
Acquired von Willebrand syndrome in inflammatory bowel disease 49
Diagnostic delay in adult coeliac disease: An Italian multicentre study 48
The Italian Society of Internal Medicine choosing wisely campaign 48
Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease 48
Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease 48
Determinants of diagnostic delay in autoimmune atrophic gastritis 47
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 47
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 47
Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease 46
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 46
Reflux symptoms in professional opera soloists 45
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 44
Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study 44
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 43
The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: An Italian multicentre study 43
Poorly Cohesive Carcinoma of the Nonampullary Small Intestine: A Distinct Histologic Subtype with Prognostic Significance 43
Diet Therapy in Eosinophilic Esophagitis. Focus on a Personalized Approach 43
Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience 42
Administrative data for exploring multimorbidity in hospitalised patients 42
Safety and durability of PEG-J: a single-centre experience 42
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 42
Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy 41
QTc Interval and Mortality in a Population of SARS-2-CoV Infected Patients 41
Autoimmune diseases associated with common variable immune deficiency 41
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas 41
New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract 40
Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions 40
Editorial: determinants of diagnostic delay in autoimmune atrophic gastritis-a salutary lesson. Authors' reply 40
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 40
COVID-19-related symptom clustering in a primary care vs internal medicine setting 40
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers 40
The challenging diagnosis of autoimmune atrophic gastritis 38
Bringing complexity into clinical practice: An internistic approach 38
Rectal neuroendocrine cell proliferation in a patient with ulcerative colitis treated with adalimumab 38
Impact of COVID-19 in immunosuppressive drug-naïve autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease 38
Multidimensional Prognostic Index Predicts Clinical Outcome and Mortality in Hospitalised Older Patients with Diverticular Disease 38
Separation of low versus high grade Crohn's disease-associated small bowel carcinomas is improved by invasive front prognostic marker analysis 37
Histologic heterogeneity and syndromic associations of non-ampullary duodenal polyps and superficial mucosal lesions 37
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 37
Trusting internal medicine in hard times 36
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 36
Incidence and risk factors for preneoplastic and neoplastic lesions of the colon and rectum in patients under 50 referred for colonoscopy 36
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 35
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign 35
Reproducibility in the Assessment of the Components of a Clinical Complexity Index 35
Validation of the Red Flags Index for Early Diagnosis of Crohn's Disease: A Prospective Observational IG-IBD Study Among General Practitioners 35
Allergic manifestations in autoimmune gastrointestinal disorders 35
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 35
Malabsorption and malabsorption tests: Do they still matter? 34
Clinical complexity and hospital admissions in the December holiday period 34
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study 33
Nivolumab-associated active neutrophilic gastritis 33
Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI] 33
Impaired Quality of Life in Patients with Autoimmune Atrophic Gastritis 33
How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease 32
From sadness to stiffness: the spleen’s progress 32
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 32
Anemia in patients with Covid-19: pathogenesis and clinical significance 32
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 31
Does biopsy still have a role for adult coeliac disease? 31
Early-onset versus late-onset Crohn's disease: An Italian cohort study 31
Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab 31
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 31
High prevalence of acute stress disorder and persisting symptoms in ICU survivors after COVID-19 31
Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn’s disease-associated small bowel carcinoma 31
Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease 31
Seronegative autoimmune diseases: A challenging diagnosis 30
Increase of Deep Intraepithelial Lymphocytes in the Oxyntic Mucosa of Patients With Potential and Overt Autoimmune Gastritis 30
Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease 30
Frailty and the gut 30
Diagnostic reasoning in internal medicine: a practical reappraisal 30
Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer 30
Serum markers of refractoriness and enteropathy-associated t-cell lymphoma in coeliac disease 30
Totale 4.338
Categoria #
all - tutte 23.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 6 7 8 5
2019/2020788 187 314 5 12 2 17 27 22 17 48 55 82
2020/2021250 11 29 8 11 13 41 3 65 14 32 14 9
2021/2022657 5 3 27 6 12 16 11 77 43 32 72 353
2022/20232.513 206 177 20 134 147 212 46 125 1.303 33 79 31
2023/20241.147 119 195 48 77 181 305 122 86 14 0 0 0
Totale 5.649